Chronic Kidney Disease Stage V, End-Stage Renal Disease, Hemodialysis
Conditions
Keywords
Autogenic Relaxation, Murottal Therapy, Anxiety, Sleep Quality, Hemodynamics
Brief summary
This quasi-experimental study aims to evaluate the effect of combined autogenic relaxation and Surah Ar-Rahman murottal therapy on anxiety, sleep quality, and hemodynamic parameters in hemodialysis patients. A pretest-posttest control group design will be used involving 76 participants undergoing routine hemodialysis. Participants will be assigned to an intervention group receiving structured autogenic relaxation followed by murottal therapy and a control group receiving standard care with music listening. Anxiety, sleep quality, and hemodynamic parameters will be measured at baseline and after a 6-week intervention period. The findings are expected to support the use of non-pharmacological and spiritual-based interventions in improving psychological and physiological outcomes in hemodialysis patients.
Detailed description
This study applies a quasi-experimental pretest-posttest control group design. The intervention group receives structured autogenic relaxation followed by Surah Ar-Rahman murottal therapy for 10-15 minutes per session, twice weekly for six weeks. The control group receives standard hemodialysis care with music listening. Anxiety, sleep quality, and hemodynamic parameters are assessed before and after the intervention.
Interventions
BEHAVIORALAutogenic Relaxation and Surah Ar-Rahman Murottal Therapy
A structured non-pharmacological intervention consisting of autogenic relaxation techniques including breathing regulation, muscle relaxation, and self-suggestion, followed by listening to Surah Ar-Rahman murottal recitation using earphones. Each session lasts 10-15 minutes and is conducted twice weekly for six weeks during routine hemodialysis.
OTHERlistening to dangdut music
listening to dangdut music for 10 to 15 minutes within 6 weeks
Sponsors
Universitas Muhammadiyah Surakarta
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Intervention model description
This study uses a parallel assignment quasi-experimental pretest-posttest control group design. Participants are assigned into two groups: an intervention group receiving structured autogenic relaxation combined with Surah Ar-Rahman murottal therapy, and a control group receiving standard hemodialysis care with music listening. Both groups undergo baseline (pretest) and post-intervention (posttest) assessments of anxiety, sleep quality, and hemodynamic parameters. The intervention is administered twice weekly for six weeks.
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
1. Patients diagnosed with stage V chronic kidney disease. 2. Undergoing scheduled hemodialysis at least twice a week for 6 weeks. 3. Outpatients and aged 18-65 years. 4. Muslim. 5. Cooperative and able to communicate verbally. 6. Willing to be a respondent by signing an informed consent form.
Exclusion criteria
1. Having a severe heart condition or an unstable critical condition. 2. Having a severe psychiatric disorder (schizophrenia, major depression). 3. Having a cognitive, hearing, or speech disorder that impedes communication. 4. Taking antidepressants, anxiolytics, or neuroleptics that may affect psychological measurement results.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Anxiety | Baseline and after completion of the 6-week intervention | Change in anxiety level measured using the Zung Self-Rating Anxiety Scale (ZSAS; range 20-80), where higher scores indicate greater anxiety, from baseline to after completion of the 6-week intervention. |
| Sleep Quality | Baseline and after completion of the 6-week intervention. | Change in sleep quality measured using the Pittsburgh Sleep Quality Index (PSQI; range 0-21), where higher scores indicate poorer sleep quality, from baseline to after completion of the 6-week intervention. |
| Blood Presure | Baseline and after completion of the 6-week intervention | Change in systolic blood pressure (mmHg), measured using a calibrated digital sphygmomanometer, from baseline to after completion of the 6-week intervention. |
| Heart Rate | Baseline and after completion of the 6-week intervention | Change in heart rate (beats per minute, bpm), measured using a digital bedside patient monitor, from baseline to after completion of the 6-week intervention. |
Countries
Indonesia
Contacts
CONTACTDyan Kurniasari, S.Kep.,Ns
Outcome results
None listed